These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24530566)

  • 1. Effective protocol for the investigation of physicochemical and conformational stability and aggregation kinetics measurements of therapeutic IgG2 monoclonal antibody.
    Aboel Dahab A; El-Hag D
    J Immunol Methods; 2014 Mar; 405():154-66. PubMed ID: 24530566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of high-throughput biophysical methods to identify stabilizing excipients for a model IgG2 monoclonal antibody: conformational stability and kinetic aggregation measurements.
    Cheng W; Joshi SB; He F; Brems DN; He B; Kerwin BA; Volkin DB; Middaugh CR
    J Pharm Sci; 2012 May; 101(5):1701-20. PubMed ID: 22323186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions.
    Bhambhani A; Kissmann JM; Joshi SB; Volkin DB; Kashi RS; Middaugh CR
    J Pharm Sci; 2012 Mar; 101(3):1120-35. PubMed ID: 22147527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of acid exposure on the conformation, stability, and aggregation of monoclonal antibodies.
    Ejima D; Tsumoto K; Fukada H; Yumioka R; Nagase K; Arakawa T; Philo JS
    Proteins; 2007 Mar; 66(4):954-62. PubMed ID: 17154421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the relevance of local conformational stability and dynamics to the aggregation propensity of an IgG1 and IgG2 monoclonal antibodies.
    Thakkar SV; Sahni N; Joshi SB; Kerwin BA; He F; Volkin DB; Middaugh CR
    Protein Sci; 2013 Oct; 22(10):1295-305. PubMed ID: 23893936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational and Colloidal Stabilities of Isolated Constant Domains of Human Immunoglobulin G and Their Impact on Antibody Aggregation under Acidic Conditions.
    Yageta S; Lauer TM; Trout BL; Honda S
    Mol Pharm; 2015 May; 12(5):1443-55. PubMed ID: 25871775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational implications of an inversed pH-dependent antibody aggregation.
    Perico N; Purtell J; Dillon TM; Ricci MS
    J Pharm Sci; 2009 Sep; 98(9):3031-42. PubMed ID: 18803243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a folding model and in situ spectroscopic techniques for rational formulation development and stability testing of monoclonal antibody therapeutics.
    Rao G; Iyer V; Kosloski MP; Pisal DS; Shin E; Middaugh CR; Balu-Iyer SV
    J Pharm Sci; 2010 Apr; 99(4):1697-706. PubMed ID: 19798762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of solvent environment on the conformation and stability of human polyclonal IgG in solution.
    Szenczi A; Kardos J; Medgyesi GA; Závodszky P
    Biologicals; 2006 Mar; 34(1):5-14. PubMed ID: 16168667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations between changes in conformational dynamics and physical stability in a mutant IgG1 mAb engineered for extended serum half-life.
    Majumdar R; Esfandiary R; Bishop SM; Samra HS; Middaugh CR; Volkin DB; Weis DD
    MAbs; 2015; 7(1):84-95. PubMed ID: 25524268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cosolutes in the aggregation kinetics of monoclonal antibodies.
    Nicoud L; Sozo M; Arosio P; Yates A; Norrant E; Morbidelli M
    J Phys Chem B; 2014 Oct; 118(41):11921-30. PubMed ID: 25243487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Throughput Prediction Approach for Monoclonal Antibody Aggregation at High Concentration.
    Zidar M; Šušterič A; Ravnik M; Kuzman D
    Pharm Res; 2017 Sep; 34(9):1831-1839. PubMed ID: 28593474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonnative aggregation of an IgG1 antibody in acidic conditions: part 1. Unfolding, colloidal interactions, and formation of high-molecular-weight aggregates.
    Brummitt RK; Nesta DP; Chang L; Chase SF; Laue TM; Roberts CJ
    J Pharm Sci; 2011 Jun; 100(6):2087-103. PubMed ID: 21213308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular dichroism spectroscopy as a tool for monitoring aggregation in monoclonal antibody therapeutics.
    Joshi V; Shivach T; Yadav N; Rathore AS
    Anal Chem; 2014 Dec; 86(23):11606-13. PubMed ID: 25350583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of pH and ionic strength on protein-protein interactions, unfolding, and aggregation for IgG1 antibodies.
    Sahin E; Grillo AO; Perkins MD; Roberts CJ
    J Pharm Sci; 2010 Dec; 99(12):4830-48. PubMed ID: 20821389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein structural conformation and not second virial coefficient relates to long-term irreversible aggregation of a monoclonal antibody and ovalbumin in solution.
    Bajaj H; Sharma VK; Badkar A; Zeng D; Nema S; Kalonia DS
    Pharm Res; 2006 Jun; 23(6):1382-94. PubMed ID: 16715374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly concentrated monoclonal antibody solutions: direct analysis of physical structure and thermal stability.
    Harn N; Allan C; Oliver C; Middaugh CR
    J Pharm Sci; 2007 Mar; 96(3):532-46. PubMed ID: 17083094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the role of salt type and concentration on the stability behavior of a monoclonal antibody solution.
    Arosio P; Jaquet B; Wu H; Morbidelli M
    Biophys Chem; 2012 Jul; 168-169():19-27. PubMed ID: 22750560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of Colloidal and Conformational Stabilities to Aggregate Formation in a Monoclonal Antibody.
    Oyama H; Koga H; Tadokoro T; Maenaka K; Shiota A; Yokoyama M; Noda M; Torisu T; Uchiyama S
    J Pharm Sci; 2020 Jan; 109(1):308-315. PubMed ID: 31669120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal Antibodies Follow Distinct Aggregation Pathways During Production-Relevant Acidic Incubation and Neutralization.
    Skamris T; Tian X; Thorolfsson M; Karkov HS; Rasmussen HB; Langkilde AE; Vestergaard B
    Pharm Res; 2016 Mar; 33(3):716-28. PubMed ID: 26563206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.